Tech

Gene-Editing Drug Shows Promising Results in Cholesterol Reduction

Updated 2026-05-28 14:50 UTC 1 source Positive

A small trial of a gene-editing drug has shown significant reductions in bad cholesterol, slashing levels by 62% in participants. The interim results are positive but based on data from only 35 people.

Coverage timeline — 1 article

Ars Technica

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

2026-05-28 13:39 UTC